Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis

被引:115
作者
Johnson, AH
Frierson, HF
Zaika, A
Powell, SM
Roche, J
Crowe, S
Moskaluk, CA
El-Rifai, W
机构
[1] Univ Virginia Hlth Syst, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA
[2] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22908 USA
关键词
D O I
10.1016/S0002-9440(10)62999-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Trefoil factor-1 (Tff1) expression is remarkably down-regulated in nearly all human gastric cancers. Therefore, we used the Tff1 knockout mouse model to detect molecular changes in preneoplastic gastric dysplasia. Oligonucleotide microarray gene expression analysis of gastric dysplasia of Tffl -/- mice was compared to that of normal gastric mucosa of wild-type mice. The genes most overexpressed in Tff1-/- mice included claudin-7 (CLDN7), early growth response-1 (EGR1), and epithelial membrane protein-1 (EMP1). Quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry showed that Cldn7 was overexpressed in all 10 Tff1-/- gastric dysplasia samples. Comparison with our serial analysis of gene expression database of human gastric cancer revealed similar deregulation in human gastric cancers. Quantitative real-time reverse transcriptase-polymerase chain reaction of human gastric adenocarcinoma samples indicated that, of these three genes, CLDN7 was the most frequently up-regulated gene. Using immunohistochemistry, both mouse and human gastric glands overexpressed. Cldn7 in dysplastic but not surrounding normal glands. Cldn7 expression was observed in 30% of metaplasia, 80% of dysplasia, and 70% of gastric adenocarcinomas. Interestingly, 82% of human intestinal-type gastric adenocarcinomas expressed Cldn7 whereas diffuse-type gastric adenocarcinomas did not (P < 0.001). These results suggest that Cldn7 expression is an early event in gastric tumorigenesis that is maintained throughout tumor progression.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 33 条
  • [1] Decreased abundance of trefoil factor 1 transcript in the majority of gastric carcinomas
    Beckler, AD
    Roche, JK
    Harper, JC
    Petroni, G
    Frierson, HF
    Moskaluk, CA
    El-Rifai, W
    Powell, SM
    [J]. CANCER, 2003, 98 (10) : 2184 - 2191
  • [2] The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis
    Bossenmeyer-Pourié, C
    Kannan, R
    Ribieras, S
    Wendling, C
    Stoll, I
    Thim, L
    Tomasetto, C
    Rio, MC
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 157 (05) : 761 - 770
  • [3] Induction and regulation of epithelial-mesenchymal transitions
    Boyer, B
    Vallés, AM
    Edme, N
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1091 - 1099
  • [4] Buckhaults P, 2001, CANCER RES, V61, P6996
  • [5] Calnan DP, 1999, J PATHOL, V188, P312, DOI 10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO
  • [6] 2-P
  • [7] Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma
    Carvalho, R
    Kayademir, T
    Soares, P
    Canedo, P
    Sousa, S
    Oliveira, C
    Leistenschneider, P
    Seruca, R
    Gött, P
    Blin, N
    Carneiro, F
    Machado, JC
    [J]. LABORATORY INVESTIGATION, 2002, 82 (10) : 1319 - 1326
  • [8] El-Rifai W, 2002, CANCER RES, V62, P4061
  • [9] El-Rifai W, 2002, CANCER RES, V62, P6823
  • [10] Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa
    El-Rifai, W
    Frierson, HF
    Moskaluk, CA
    Harper, JC
    Petroni, GR
    Bissonette, EA
    Jones, DR
    Knuutila, S
    Powell, SM
    [J]. GASTROENTEROLOGY, 2001, 121 (03) : 592 - 598